Rosetta Genomics (ROSG) Misses Q1 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. QQQ
8. LDOS
9. HUM
10. KTOS

Go back to Rosetta Genomics (ROSG) Misses Q1 EPS by 2c

Rosetta Genomics Reports 2016 First Quarter Financial Results

May 19, 2016 8:01 AM EDT

Record Quarterly Clinical Testing Revenues of $2.6 million

Conference call begins today at 10:00 a.m. Eastern time

PHILADELPHIA & REHOVOT, Israel--(BUSINESS WIRE)-- Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based and other molecular diagnostics, today reported financial results for the three months ended March 31, 2016.

Recent developments include:

Expanded molecular diagnostics test menu with the launch of three new product offerings in common hematologic cancers and solid tumors; Received conditional approval status from... More